Trade Report: Today: Chemed Corp. (CHE) Position Maintained by Whittier Trust Co.

Today: Chemed Corp. (CHE) Position Maintained by Whittier Trust Co.

Whittier Trust Co. continued to hold its stake in shares of Chemed Corp. (NYSE:CHE) during the second quarter, Holdings Channel reports. The fund owned 1,125 shares of the company’s stock at the end of the second quarter. Whittier Trust Co.’s holdings in Chemed Corp. were worth $153,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. M&T Bank Corp boosted its stake in Chemed Corp. by 2.2% in the first quarter. M&T Bank Corp now owns 3,052 shares of the company’s stock valued at $413,000 after buying an additional 65 shares in the last quarter. Magnetar Financial LLC boosted its stake in Chemed Corp. by 8.3% in the first quarter. Magnetar Financial LLC now owns 1,914 shares of the company’s stock valued at $259,000 after buying an additional 147 shares in the last quarter. Mount Lucas Management LP boosted its stake in Chemed Corp. by 10.6% in the first quarter. Mount Lucas Management LP now owns 2,169 shares of the company’s stock valued at $294,000 after buying an additional 207 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. boosted its stake in Chemed Corp. by 6.6% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 5,636 shares of the company’s stock valued at $763,000 after buying an additional 350 shares in the last quarter. Finally, Capstone Asset Management Co. boosted its stake in Chemed Corp. by 17.2% in the second quarter. Capstone Asset Management Co. now owns 2,480 shares of the company’s stock valued at $338,000 after buying an additional 364 shares in the last quarter. 98.64% of the stock is owned by hedge funds and other institutional investors.

Chemed Corp. (NYSE:CHE) traded down 0.25% on Friday, reaching $139.80. The company’s stock had a trading volume of 93,776 shares. Chemed Corp. has a 12 month low of $124.77 and a 12 month high of $160.12. The company has a 50-day moving average price of $138.86 and a 200 day moving average price of $136.25. The company has a market cap of $2.26 billion, a P/E ratio of 22.17 and a beta of 1.17.

Chemed Corp. (NYSE:CHE) last posted its quarterly earnings results on Monday, July 25th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.08. Chemed Corp. had a return on equity of 24.12% and a net margin of 6.93%. The company earned $290 million during the quarter, compared to analysts’ expectations of $393.50 million. During the same quarter in the previous year, the firm earned $1.71 EPS. Chemed Corp.’s revenue was up 2.2% on a year-over-year basis. On average, equities research analysts anticipate that Chemed Corp. will post $7.25 EPS for the current fiscal year.

CHE has been the subject of several research reports. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $155.00 price objective on shares of Chemed Corp. in a research report on Tuesday, September 27th. RBC Capital Markets restated a “sector perform” rating and issued a $162.00 target price (up from $136.00) on shares of Chemed Corp. in a research note on Wednesday, July 27th. Royal Bank Of Canada upped their target price on Chemed Corp. from $136.00 to $162.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 27th. Zacks Investment Research lowered Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Friday, July 29th. Finally, JMP Securities restated a “hold” rating on shares of Chemed Corp. in a research note on Sunday, September 4th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Chemed Corp. presently has a consensus rating of “Hold” and a consensus price target of $161.50.

In other news, insider Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $141.67, for a total transaction of $283,340.00. Following the completion of the transaction, the insider now owns 39,867 shares of the company’s stock, valued at approximately $5,647,957.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Donald E. Saunders sold 500 shares of the business’s stock in a transaction on Monday, August 8th. The stock was sold at an average price of $144.32, for a total value of $72,160.00. Following the transaction, the director now directly owns 10,786 shares of the company’s stock, valued at approximately $1,556,635.52. The disclosure for this sale can be found here. Insiders own 5.32% of the company’s stock.

About Chemed Corp.

Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Related posts

Leave a Comment